Questions for PP Talks – Covid-19 & Children
1. Rationale?
a. Symptoms less severe than in adults
b. Children may carry the virus w/o S/S, but may transfer it
c. Data is variable and in many cases based on limited groups or on case reports
2. What do we know?
a. 22% of US population is children
b. 1.7% are reported cases (similar to China data)
c. Case breakdown =
i. 10-17 y/o = 60%
ii. 1 y/o = 15%
iii. 1-4 y/o = 11%
iv. 5-9 y/o = 15%
v. 57% males
d. Comps to adults
i. Peds experience less fever, cough, SOB -- 73% peds vs. 93% adults
ii. Hospitalization – 5.7% peds vs. 10% adults
3. Treatments?
a. Population at risk – no widespread testing, no testing for mild S/S
b. Perinatal transmission to neonates – guidelines require mandatory testing of neonates
c. Infants at higher risk than older children
d. Extrapolate treatments for adults
i. Prevention = hand washing, face masks, social distancing
ii. Behavioral changes = target stress, excessive worry, sadness, poor eating habits, unhealthy sleep habits, difficulties with attention and concentration
iii. Remdesivir – for hospital, severe disease – available for children through FDA Emergency Use Authorization OR through compassionate use program
4. Risks?
a. Standard vaccinations and wellness checks
b. PMIS-TS
